Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2024 07:30 ET | Source: COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12,...
November 24, 2022 09:00 ET | Source: PatchMD

PatchMD Launch New Shopify Website To Keep Up With Demand For The 2022-2023 Holiday Season

Las Vegas, Nevada, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Founded by a team of experts with over 60 years of combined experience in the over-the-counter pharmaceutical and medical device products...
June 04, 2021 09:30 ET | Source: The Insight Partners

Pharmaceutical Excipients Market to Outstrip $9,873.53 Million by 2027 Growing Sturdy at 5.5% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com

Pune, India., June 04, 2021 (GLOBE NEWSWIRE) -- Pharmaceutical Excipients Market: Key InsightsAccording to our new research study on “Pharmaceutical Excipients Market to 2027 – Global Analysis and...
January 21, 2021 04:30 ET | Source: Juva Life Inc.

Juva Life Initiates Clinical Registry as First Step in Building Evidence-Based Cannabis Technology Platform

VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California-based life science...
April 15, 2019 06:15 ET | Source: Biofrontera AG

Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019

Leverkusen, Germany, April 15, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
March 27, 2019 09:05 ET | Source: Biofrontera AG

Changes in the composition of the Supervisory Board

Leverkusen, Germany, March 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that the...
November 26, 2018 13:08 ET | Source: Biofrontera AG

Biofrontera to Participate in Two Upcoming Investor Conferences

Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
September 03, 2018 05:35 ET | Source: Biofrontera AG

Correction of news release from August 31, 2018: Biofrontera reports significant revenue growth for the first 6 months of 2018

Leverkusen, Germany, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
February 22, 2018 09:00 ET | Source: Mount Tam Biotechnologies Inc.

Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased...
September 28, 2016 05:35 ET | Source: Transparency Market Research

Bio-Pharmaceutical Logistics Market: Rising Unmet Medical Needs Pushes Bio-Pharmaceutical Companies Improve Logistics, Observes TMR

Albany - New York, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research discusses the logistics market for the bio-pharmaceuticals industry in its recent research report. It explains...